Notes for: Drugs affecting the immune responseLast edited [04/07/2012 11:11:42]
CSM Warning: Prescribers and patients who are receiving infliximab need to be aware of the risk of developing infections upon starting therapy and to be especially vigilant for signs of infection throughout treatment. If active tuberculosis is suspected (persistent cough, wasting/weight loss, low grade fever), infliximab treatment should be withheld until the infection has been treated.